The last decade has seen a rise in interest among Malaysians in alternative ways of treating illnesses, including stem cell therapy, in addition to the traditional forms of medical treatment. Although conventional treatments are designed to improve health, they work differently from stem cell therapy and are governed by differing laws. By understanding how each method works, patients will be able to make an educated decision about how to treat themselves in today’s rapidly changing medical environment.
Conventional Medical Treatments in Malaysia
Traditional methods of treating illness are still the backbone of medical treatment in Malaysia. Traditional treatments include the use of drugs, surgery, physical therapy and lifestyle-based management techniques. Many of these treatments are being utilized in a variety of public and private hospitals located throughout the nation.
These traditional methods of treating illnesses are widely supported by evidence and are recognized across the globe. The majority of them are available at public and private hospitals and are administered within the structure of a public or private hospital setting. For example, Hospital Kuala Lumpur, a major public tertiary hospital located in Malaysia provides free and/or subsidized access to a wide array of evidence-based treatments.
Examples of conventional management of osteoarthritis, as mentioned earlier, include pharmacologic interventions (NSAIDS), physical therapy (to preserve mobility) and orthopedic interventions (joint replacement) when the damage to the joint has progressed to a point where structural repair is necessary.
What Is Stem Cell Therapy?
Stem cell therapy is a subcategory of regenerative medicine which utilizes specialized cells capable of developing into various types of tissues and stimulating repair mechanisms in the body.
In Malaysia, stem cell therapy involves isolating stem cells from either bone marrow, fat tissue, umbilical cord tissue from the mother or other ethically-sourced materials. After processing, the stem cells are then returned to the affected area of injury — such as joints, muscle tissue, etc. — to stimulate the body to repair itself rather than just to alleviate the symptoms of the condition.
Regulations and Legalities
Another way that conventional treatments and stem cell therapy differ is the regulatory framework governing them.
Conventional treatments have been regulated in Malaysia for a number of decades and follow established protocols developed by the Ministry of Health. Conventional treatments are based upon a large amount of clinical evidence and decades of practice.
In Malaysia, stem cell therapy is regulated; however, the approved medical uses of the therapy are relatively limited compared to conventional treatments. While bone marrow transplantations (for leukemia and lymphoma) are examples of established global stem cell therapies, many of the other medical applications for stem cell therapy are experimental and are subject to the same stringent review processes.
Under the guidelines of the **Ministry of Health Guidelines on Stem Cell and Cell-Based Research and Therapy**, any stem cell therapy must be carried out in accordance with the ethical, safety, and quality standards as outlined by organizations such as the National Pharmaceutical Regulatory Agency (NPRA) and independent ethics committees.
Moreover, it is important to emphasize that treatments sold outside of the approved clinical context (i.e., as “anti-aging” miracle cures) may not have official approval from the Ministry of Health and can pose serious risks to the patients. Patients should verify whether a clinic is appropriately licensed and that the treatment falls within the approved parameters of the Ministry of Health.
Symptom Control vs. Tissue Regeneration
Conventional treatments generally focus on controlling the symptoms of the disease and restoring function by employing medical devices and/or pharmaceuticals that have a long history of safe usage. Examples of these treatments include the administration of analgesics and ant-inflammatory agents for the management of pain associated with osteoarthritis, and physiotherapy for the maintenance of mobility and strength in the limbs. However, conventional treatments do not typically regenerate lost tissue.
On the other hand, the primary goal of stem cell therapy is to regenerate lost or damaged tissue, thereby addressing the root cause of the disease. For example, in the case of osteoarthritis, it is believed that stem cells will induce the regeneration of cartilage tissue at the cellular level, something that is difficult to achieve with the administration of conventional pharmaceuticals.
Because of the fundamental differences between the two approaches, it is common to describe the benefits of stem cell therapy as potentially providing long-lasting results compared to those achieved with conventional treatments, which are primarily focused on alleviating the symptoms of a condition.
However, it is essential to recognize that the outcomes resulting from stem cell therapy can vary greatly, with some patients experiencing significant improvement in their condition over several months after undergoing treatment, while others experience only minor changes or no changes at all. It is also worth noting that the long-term data (greater than 5 years) for most of the current applications of stem cell therapy are still under investigation and are not considered standard clinical practices.
Safety, Side Effects and Risks
It is well-known that conventional treatments entail risks that have been documented extensively. For example, surgery carries risks such as complications related to anesthesia, post-operative infection and prolonged recovery periods, while long-term administration of pain-relieving medications may result in gastrointestinal problems.
Stem cell therapy, on the other hand, is characterized by fewer short-term adverse events compared to conventional treatments. Examples of the adverse events that have been reported in the literature include mild swelling and/or discomfort at the site of the injections. As autologous stem cells (obtained from the patient’s own body) do not pose the risk of immunologically-mediated rejection, the risk of adverse events associated with stem cell therapy is further minimized.
While the risks associated with stem cell therapy are minimal, there are important caveats to consider. There is a real concern regarding the unapproved and/or unregulated delivery of stem cell therapies — a problem that is present in any market where there is high demand relative to oversight. Therefore, if stem cell procedures are delivered by unapproved/unregulated providers — as is possible in any market — the risks could include infection, inflammatory reaction, or even ineffective or contaminated products. Therefore, it is very important to ensure that you receive your treatment from a reputable and licensed facility.
Cost Implications
Publicly-funded conventional treatments such as physiotherapy, prescription medications, and public hospital surgeries are generally less expensive and/or are free of charge to citizens utilizing public health services in Malaysia.
As a result, stem cell therapy is generally delivered in private clinics and can be costly. Prices for stem cell therapies, e.g., stem cell therapy for osteoarthritis, can vary significantly depending upon the type of stem cells utilized, the private clinic delivering the treatment and the complexity of the treatment process.
This investment in stem cell therapy represents the advanced technology involved in the delivery of the treatment, as well as the personalized nature of regenerative therapies.
Closing Thoughts: The Role of Each Treatment Option in Providing Health Care
While conventional treatments and stem cell therapy have distinct roles in health care, both are complementary. Conventional treatments represent the cornerstone of health care and are critical to the provision of emergency care/surgery, chronic symptom management, and evidence-based treatments validated by extensive research. Stem cell therapy represents new opportunities to regenerate damaged tissue and potentially avoid the need for invasive surgical interventions in patients with musculoskeletal or degenerative disorders. However, the use of stem cell therapies in mainstream clinical settings continues to be approached with caution and based on evidence-based criteria.
Therefore, the decision to utilize either stem cell therapy or conventional treatments should be made based upon the evidence supporting the treatment, recommendations from medical specialists, and careful consideration of the risks and benefits, and regulatory approvals. Additionally, in many cases, the utilization of both treatments — i.e., conventional treatments to stabilize the condition followed by the introduction of regenerative therapies — may offer the best opportunity for successful outcomes.